Heyndrickx L - Search Results

1

Five accelerated schedules for the tick-borne encephalitis vaccine FSME-Immun® in last-minute travellers: an open-label, single-centre, randomized controlled pilot trial.

Berens-Riha N, Andries P, Aerssens A, Ledure Q, Van Der Beken Y, Heyndrickx L, Genbrugge E, Tsoumanis A, Van Herrewege Y, Ariën KK, Van Innis M, Vanbrabant P, Soentjens P; FASTBEPROTECT Research Team. Berens-Riha N, et al. Among authors: heyndrickx l. J Travel Med. 2024 Oct 19;31(7):taad053. doi: 10.1093/jtm/taad053. J Travel Med. 2024. PMID: 37074147 Free PMC article. Clinical Trial.

2

Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.

Boutonnet N, Janssens W, Boutton C, Verschelde JL, Heyndrickx L, Beirnaert E, van der Groen G, Lasters I. Boutonnet N, et al. Among authors: heyndrickx l. J Virol. 2002 Aug;76(15):7595-606. doi: 10.1128/jvi.76.15.7595-7606.2002. J Virol. 2002. PMID: 12097573 Free PMC article.

3

Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies.

Haldar B, Burda S, Williams C, Heyndrickx L, Vanham G, Gorny MK, Nyambi P. Haldar B, et al. Among authors: heyndrickx l. PLoS One. 2011 Feb 23;6(2):e17253. doi: 10.1371/journal.pone.0017253. PLoS One. 2011. PMID: 21383841 Free PMC article.

4

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity.

Cham F, Zhang PF, Heyndrickx L, Bouma P, Zhong P, Katinger H, Robinson J, van der Groen G, Quinnan GV Jr. Cham F, et al. Among authors: heyndrickx l. Virology. 2006 Mar 30;347(1):36-51. doi: 10.1016/j.virol.2005.11.019. Epub 2005 Dec 27. Virology. 2006. PMID: 16378633 Free article.

5

Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPT.

Van den Bergh R, Morin S, Sass HJ, Grzesiek S, Vekemans M, Florence E, Tran HT, Imiru RG, Heyndrickx L, Vanham G, De Baetselier P, Raes G. Van den Bergh R, et al. Among authors: heyndrickx l. PLoS One. 2012;7(4):e35074. doi: 10.1371/journal.pone.0035074. Epub 2012 Apr 6. PLoS One. 2012. PMID: 22493731 Free PMC article.

6

HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon.

Zhong P, Burda S, Urbanski M, Kenfack H, Tongo M, Heyndrickx L, Nanfack A, Shang J, Agyingi L, Zolla-Pazner S, Zekeng L, Nyambi P. Zhong P, et al. Among authors: heyndrickx l. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):495-505. doi: 10.1097/00126334-200212150-00007. J Acquir Immune Defic Syndr. 2002. PMID: 12473838

7

Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.

Van den Bosch GA, Van Gulck E, Ponsaerts P, Nijs G, Lenjou M, Apers L, Kint I, Heyndrickx L, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF. Van den Bosch GA, et al. Among authors: heyndrickx l. J Immunother. 2006 Sep-Oct;29(5):512-23. doi: 10.1097/01.cji.0000210385.48327.1e. J Immunother. 2006. PMID: 16971807

8

Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.

Davis D, Donners H, Willems B, Vermoesen T, Heyndrickx L, Colebunders R, van der Groen G. Davis D, et al. Among authors: heyndrickx l. J Med Virol. 2003 Nov;71(3):332-42. doi: 10.1002/jmv.10490. J Med Virol. 2003. PMID: 12966537

9

Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.

Ariën KK, Gali Y, El-Abdellati A, Heyndrickx L, Janssens W, Vanham G. Ariën KK, et al. Among authors: heyndrickx l. Virology. 2006 Mar 30;347(1):65-74. doi: 10.1016/j.virol.2005.11.045. Epub 2005 Dec 28. Virology. 2006. PMID: 16386774 Free article.

10

CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.

Van Herrewege Y, Morellato L, Descours A, Aerts L, Michiels J, Heyndrickx L, Martin L, Vanham G. Van Herrewege Y, et al. Among authors: heyndrickx l. J Antimicrob Chemother. 2008 Apr;61(4):818-26. doi: 10.1093/jac/dkn042. Epub 2008 Feb 12. J Antimicrob Chemother. 2008. PMID: 18270220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters